John V. Oyler | |
|---|---|
| Born | 1968 Pittsburgh, Pennsylvania |
| Alma mater | Massachusetts Institute of Technology |
| Occupation | Businessman |
| Known for | BeiGene |
John V. Oyler (born 1968) is an American executive. [1] He is known for co-founding BeOne, a biotechnology company, with biochemist Xiaodong Wang. [2]
Oyler grew up in Pittsburgh, Pennsylvania. He attended the Massachusetts Institute of Technology. [3] He graduated with a degree in mechanical engineering in 1990. [2] [4]
Oyler began his career as a consultant at McKinsey & Company, which often involved traveled to China. [5] During his time at McKinsey, he earned an MBA degree from Stanford University and continued to work there after graduate school. [2]
Oyler joined Genta, a biotechnology company focused on cancer drugs, in 1997. At Genta, Oyler hired new management and grew the company's valuation from a few million dollars to $1.7 billion.
In 1998, Oyler was a founder of Telephia, a telecom research company where he served as president. [6] [5] [7] Nielsen Holdings acquired Telephia in 2007. [8] Oyler was also headed Galenea, a company focused on treatments for psychiatric diseases, [9] from 2002 to 2004. [10]
In 2005, Oyler returned to China [5] and co-founded BioDuro, a contract research organization. [9] PPD acquired BioDuro in 2009. [11]
Oyler co-founded BeiGene in 2010 with Chinese biochemist Xiaodong Wang, whom Oyler met while working at BioDuro. [2]
BeiGene has developed two cancer medicines, namely Tevimbra, a checkpoint inhibitor, and Brukinsa, a Bruton's tyrosine kinase inhibitor. [3] As of 2023, BeiGene had 10,000 employees. [12]
Oyler is married and has one daughter.